Search Results - "Touyz, R."

Refine Results
  1. 1

    Hope for resistant hypertension through BrigHTN and PRECISION by Touyz, R. M., Harrison, D. G.

    Published in Nature reviews. Nephrology (01-04-2023)
    “…An estimated 10–15% of individuals with hypertension are resistant to available antihypertensive therapies. Findings from two new clinical trials — BrigHTN and…”
    Get full text
    Journal Article
  2. 2

    Anti‐atherosclerotic effect of the angiotensin 1–7 mimetic AVE0991 is mediated by inhibition of perivascular and plaque inflammation in early atherosclerosis by Skiba, D S, Nosalski, R, Mikolajczyk, T P, Siedlinski, M, Rios, F J, Montezano, A C, Jawien, J, Olszanecki, R, Korbut, R, Czesnikiewicz‐Guzik, M, Touyz, R M, Guzik, T J

    Published in British journal of pharmacology (01-11-2017)
    “…Background and Purpose Inflammation plays a key role in atherosclerosis. The protective role of angiotensin 1–7 (Ang‐(1–7)) in vascular pathologies suggested…”
    Get full text
    Journal Article
  3. 3

    Critical role of Nox4-based NADPH oxidase in glucose-induced oxidative stress in the kidney: implications in type 2 diabetic nephropathy by Sedeek, M, Callera, G, Montezano, A, Gutsol, A, Heitz, F, Szyndralewiez, C, Page, P, Kennedy, C R J, Burns, K D, Touyz, R M, Hébert, R L

    “…Molecular mechanisms underlying renal complications of diabetes remain unclear. We tested whether renal NADPH oxidase (Nox) 4 contributes to increased reactive…”
    Get more information
    Journal Article
  4. 4

    Role of magnesium in the pathogenesis of hypertension by Touyz, R.M.

    Published in Molecular aspects of medicine (06-02-2003)
    “…Human essential hypertension is a complex, multifactorial, quantitative trait under polygenic control. Although the exact etiology is unknown, the fundamental…”
    Get full text
    Journal Article
  5. 5

    Reactive oxygen species and angiotensin II signaling in vascular cells -- implications in cardiovascular disease by Touyz, R M

    “…Diseases such as hypertension, atherosclerosis, hyperlipidemia, and diabetes are associated with vascular functional and structural changes including…”
    Get full text
    Journal Article
  6. 6

    Pharmacological inhibition of NOX reduces atherosclerotic lesions, vascular ROS and immune–inflammatory responses in diabetic Apoe−/− mice by Di Marco, E., Gray, S. P., Chew, P., Koulis, C., Ziegler, A., Szyndralewiez, C., Touyz, R. M., Schmidt, H. H. H. W., Cooper, M. E., Slattery, R., Jandeleit-Dahm, K. A.

    Published in Diabetologia (01-03-2014)
    “…Aims/hypothesis Enhanced vascular inflammation, immune cell infiltration and elevated production of reactive oxygen species (ROS) contribute significantly to…”
    Get full text
    Journal Article
  7. 7
  8. 8

    c-Src Induces Phosphorylation and Translocation of p47phox: Role in Superoxide Generation by Angiotensin II in Human Vascular Smooth Muscle Cells by Touyz, R M, Yao, G, Schiffrin, E L

    “…OBJECTIVES—The aim of this study was to determine molecular mechanisms whereby c-Src regulates angiotensin II (Ang II)-mediated NAD(P)H oxidase-derived ·O2 in…”
    Get full text
    Journal Article
  9. 9

    Aldosterone and Angiotensin II Synergistically Stimulate Migration in Vascular Smooth Muscle Cells Through c-Src–Regulated Redox-Sensitive RhoA Pathways by Montezano, A C, Callera, G E, Yogi, A, He, Y, Tostes, R C, He, G, Schiffrin, E L, Touyz, R M

    “…OBJECTIVE—Synergistic interactions between aldosterone (Aldo) and angiotensin II (Ang II) have been implicated in vascular inflammation, fibrosis, and…”
    Get full text
    Journal Article
  10. 10

    Reactive Oxygen Species, Vascular Oxidative Stress, and Redox Signaling in Hypertension: What Is the Clinical Significance? by Touyz, Rhian M

    Published in Hypertension (Dallas, Tex. 1979) (01-09-2004)
    “…Metabolism of oxygen by cells generates potentially deleterious reactive oxygen species (ROS). Under normal conditions the rate and magnitude of oxidant…”
    Get full text
    Journal Article
  11. 11

    p47phox Associates With the Cytoskeleton Through Cortactin in Human Vascular Smooth Muscle Cells: Role in NAD(P)H Oxidase Regulation by Angiotensin II by Touyz, R M, Yao, G, Quinn, M T, Pagano, P J, Schiffrin, E L

    “…OBJECTIVE—We tested the hypothesis that p47phox associates with the actin cytoskeleton, enabling site-directed activation of NAD(P)H oxidase, and assessed…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Angiotensin II induces Fat1 expression/activation and vascular smooth muscle cell migration via Nox1-dependent reactive oxygen species generation by Bruder-Nascimento, T, Chinnasamy, P, Riascos-Bernal, D.F, Cau, S.B, Callera, G.E, Touyz, R.M, Tostes, R.C, Sibinga, N.E.S

    “…Abstract Fat1 is an atypical cadherin that controls vascular smooth muscle cell (VSMC) proliferation and migration. Nicotinamide adenine dinucleotide phosphate…”
    Get full text
    Journal Article
  14. 14

    Assessment of Caveolae/Lipid Rafts in Isolated Cells by Callera, G E, Bruder-Nascimento, Thiago, Touyz, R M

    “…This chapter outlines protocols to evaluate protein localization, recruitment or phosphorylation levels in cholesterol/sphingolipids-enriched cell membrane…”
    Get more information
    Journal Article
  15. 15

    Antioxidant Effects of Vitamins C and E Are Associated With Altered Activation of Vascular NADPH Oxidase and Superoxide Dismutase in Stroke-Prone SHR by Chen, Xin, Touyz, Rhian M, Park, Jeong Bae, Schiffrin, Ernesto L

    Published in Hypertension (Dallas, Tex. 1979) (01-09-2001)
    “…Ascorbic acid (vitamin C) and α-tocopherol (vitamin E) have antioxidant properties that could improve redox-sensitive vascular changes associated with…”
    Get full text
    Journal Article
  16. 16

    Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan by SCHIFFRIN, E. L, JEONG BAE PARK, INTENGAN, H. D, TOUYZ, R. M

    Published in Circulation (New York, N.Y.) (11-04-2000)
    “…Structural and functional alterations of the vasculature may contribute to complications of hypertension. Because angiotensin II may be pivotal in some of…”
    Get full text
    Journal Article
  17. 17

    Reactive oxygen species in vascular biology: implications in hypertension by Touyz, R M, Schiffrin, E L

    Published in Histochemistry and cell biology (01-10-2004)
    “…Reactive oxygen species (ROS), including superoxide (*O2-), hydrogen peroxide (H2O2), and hydroxyl anion (OH-), and reactive nitrogen species, such as nitric…”
    Get full text
    Journal Article
  18. 18

    Recent advances in angiotensin II signaling by Touyz, R M, Berry, C

    “…Angiotensin II (Ang II) is a multifunctional hormone that influences the function of cardiovascular cells through a complex series of intracellular signaling…”
    Get full text
    Journal Article
  19. 19

    Obesity, Cardiovascular and Neurodegenerative Diseases: Potential Common Mechanisms by Kuneš, J, Hojná, S, Mráziková, L, Montezano, A, Touyz, RM, Maletínská, L

    Published in Physiological research (31-07-2023)
    “…The worldwide increase in the incidence of obesity and cardiovascular and neurodegenerative diseases, e.g. Alzheimer's disease, is related to many factors,…”
    Get full text
    Journal Article
  20. 20

    Angiotensin receptors: signaling, vascular pathophysiology, and interactions with ceramide by Berry, C, Touyz, R, Dominiczak, A F, Webb, R C, Johns, D G

    “…Angiotensin II (ANG II) is a pleiotropic vasoactive peptide that binds to two distinct receptors: the ANG II type 1 (AT(1)) and type 2 (AT(2)) receptors…”
    Get more information
    Journal Article